Therapeutic peptides.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Knowledge about food-encrypted peptides and their potential can offer, in the coming decades, new tools for valuable therapies for the treatment of infectious diseases as well as metabolic, nutritional and psychiatric disorders, cardiovascular diseases, allergies and cancer.
“The knowledge about food-encrypted peptides and their potential can offer, in the coming decades, new tools for valuable therapies for the treatment of infectious diseases as well as metabolic, nutritional and psychiatric disorders, cardiovascular diseases, allergies and cancer, as suggested by Lien and Lowman (2003).”
From Bioactive Molecules Released in Food by Lactic Acid Bacteria: Encrypted Peptides and Biogenic Amines (2016) · cites this paper as Lien and Lowman, 2003
Cites
Peters, T. (1985) · Advances in protein chemistry · doi:10.1016/s0065-3233(08)60065-0 · Cited by 2,183 · see citing works
Cancer Treatment by Targeted Drug Delivery to Tumor Vasculature in a Mouse Model
Arap, W., Pasqualini, R., & Ruoslahti, E. I. (1998) · Science · doi:10.1126/science.279.5349.377 · Cited by 2,040 · see citing works
Genes Expressed in Human Tumor Endothelium
Croix, B. S., Rago, C., Velculescu, V. E., Traverso, G., Romans, K. E., Montgomery, E. A., Lal, A., Riggins, G. J., Christoph Lengauer, C., Vogelstein, B., et al. (2000) · Science · doi:10.1126/science.289.5482.1197 · Cited by 1,845 · see citing works
Microfabricated Microneedles: A Novel Approach to Transdermal Drug Delivery
Henry, S., McAllister, D. V., Allen, M. G., & Prausnitz, M. R. (1998) · Journal of Pharmaceutical Sciences · doi:10.1021/js980042+ · Cited by 1,350 · see citing works
Organ targeting In vivo using phage display peptide libraries
Pasqualini, R., & Ruoslahti, E. I. (1996) · Nature · doi:10.1038/380364a0 · Cited by 1,221 · see citing works
Anti-cancer activity of targeted pro-apoptotic peptides
Ellerby, H. M., Arap, W., Ellerby, L., Kain, R., Andrusiak, R. L., del Rio, G., Krajewski, S., Lombardo, C. R., Rao, R. V., Ruoslahti, E. I., et al. (1999) · Nature Medicine · doi:10.1038/12469 · Cited by 936 · see citing works
Soto, C. A., Sigurdsson, E. M., Morelli, L., Kumar, R., Castaño, E. M., & Frangione, B. (1998) · Nature Medicine · doi:10.1038/nm0798-822 · Cited by 874 · see citing works
Chang, S. S., Reuter, V. E., Heston, W. D. W., Bander, N. H., Grauer, L. S., & Gaudin, P. B. (1999) · PubMed · Cited by 807 · see citing works
Ultrasound-Mediated Transdermal Protein Delivery
Mitragotri, S., Blankschtein, D., & Langer, R. (1995) · Science · doi:10.1126/science.7638603 · Cited by 794 · see citing works
Tryptophan zippers: Stable, monomeric β-hairpins
Cochran, A. G., Skelton, N. J., & Starovasnik, M. A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.091100898 · Cited by 741 · see citing works
Merrifield, R. B. (1969) · Advances in enzymology and related areas of molecular biology/Advances in enzymology and related subjects · doi:10.1002/9780470122778.ch6 · Cited by 691 · see citing works
Steps toward mapping the human vasculature by phage display
Arap, W., Kolonin, M. G., Trepel, M., Lahdenranta, J., Cardó‐Vila, M., Giordano, R. J., Mintz, P. J., Ardelt, P., Yao, V. J., Vidal, C. I., et al. (2002) · Nature Medicine · doi:10.1038/nm0202-121 · Cited by 606 · see citing works
De Novo Antimicrobial Peptides with Low Mammalian Cell Toxicity
Javadpour, M. M., Juban, M. M., Lo, W. C. J., Bishop, S. M., Alberty, J. B., Cowell, S. M., Becker, C. L., & McLaughlin, M. L. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm9509410 · Cited by 597 · see citing works
Functional Mimicry of a Protein Hormone by a Peptide Agonist: The EPO Receptor Complex at 2.8 Å
Livnah, O., Stura, E. A., Johnson, D. L., Middleton, S. A., Mulcahy, L. S., Wrighton, N. C., Dower, W. J., Jolliffe, L. K., & Wilson, I. A. (1996) · Science · doi:10.1126/science.273.5274.464 · Cited by 588 · see citing works
Transgenic anopheline mosquitoes impaired in transmission of a malaria parasite
Ito, J., Ghosh, A., Moreira, L. A., Wimmer, E. A., & Jacobs‐Lorena, M. (2002) · Nature · doi:10.1038/417452a · Cited by 573 · see citing works
Tumor targeting with a selective gelatinase inhibitor
Koivunen, E., Arap, W., Valtanen, H., Rainisalo, A., Medina, O. P., Heikkilä, P., Kantor, C., Gahmberg, C. G., Salo, T. A., Konttinen, Y. T., et al. (1999) · Nature Biotechnology · doi:10.1038/11703 · Cited by 567 · see citing works
Albumin Binding as a General Strategy for Improving the Pharmacokinetics of Proteins
Dennis, M. S., Zhang, M., Meng, Y., Kadkhodayan, M., Kirchhofer, D., Combs, D., & Damico, L. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205854200 · Cited by 508 · see citing works
Cevc, G., Gebauer, D., Stieber, J., Schätzlein, A. G., & Blume, G. (1998) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(97)00177-6 · Cited by 479 · see citing works
Inhibition of Alzheimer's Amyloidosis by Peptides That Prevent β-Sheet Conformation
Soto, C. A., Kindy, M. S., Baumann, M., & Frangione, B. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.1413 · Cited by 432 · see citing works
Zwaveling, S., Mota, S. C. F., Nouta, J., Johnson, M., Lipford, G. B., Offringa, R., van der Burg, S. H., & Melief, C. J. M. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.1.350 · Cited by 416 · see citing works
Curnis, F., Sacchi, A., Borgna, L., Magni, F., Gasparri, A. M., & Corti, A. (2000) · Nature Biotechnology · doi:10.1038/81183 · Cited by 415 · see citing works
Oral delivery of insulin using pH‐responsive complexation gels
Lowman, A. M., Morishita, M., Kajita, M., NAGAI, T., & Peppas, N. A. (1999) · Journal of Pharmaceutical Sciences · doi:10.1021/js980337n · Cited by 407 · see citing works
[21] Phage display for selection of novel binding peptides
Sidhu, S. S., Lowman, H. B., Cunningham, B. C., & Wells, J. A. (2000) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(00)28406-1 · Cited by 403 · see citing works
Self-citationHaubner, R., Wester, H. J., Burkhart, F., Senekowitsch–Schmidtke, R., Weber, W., Goodman, S. L., Kessler, H., & Schwaiger, M. (2001) · PubMed · Cited by 381 · see citing works
Antimicrobial peptides of vertebrates
Ganz, T., & Lehrer, R. I. (1998) · Current Opinion in Immunology · doi:10.1016/s0952-7915(98)80029-0 · Cited by 374 · see citing works
Antimicrobial Peptides: Properties and Applicability
Hof, W. V. ‘., Veerman, E. C. I., Helmerhorst, E. J., & Amerongen, A. V. N. (2001) · Biological Chemistry · doi:10.1515/bc.2001.072 · Cited by 357 · see citing works
Serological identification of human tumor antigens
Şahin, U., Türeci, Ö., & Pfreundschuh, M. G. (1997) · Current Opinion in Immunology · doi:10.1016/s0952-7915(97)80053-2 · Cited by 314 · see citing works
Therapeutic cancer targeting peptides
Aina, O. H., Sroka, T. C., Chen, M., & Lam, K. S. (2002) · Biopolymers · doi:10.1002/bip.10257 · Cited by 313 · see citing works
Targeting the prostate for destruction through a vascular address
Arap, W., Haedicke, W., Bernasconi, M., Kain, R., Rajotte, D., Krajewski, S., Ellerby, H. M., Bredesen, D. E., Pasqualini, R., & Ruoslahti, E. I. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.241655998 · Cited by 284 · see citing works
Reversion of prion protein conformational changes by synthetic b-sheet breaker peptides
Soto, C. A., Kascsak, R. J., Saborı́o, G. P., Aucouturier, P., Wısnıewskı, T., Prelli, F. C., Kascsak, R., Méndez, E., Harris, D. A., Ironside, J. W., et al. (2000) · The Lancet · doi:10.1016/s0140-6736(99)11419-3 · Cited by 274 · see citing works
Effects of PEG conjugation on insulin properties
Hinds, K. D., & Kim, S. W. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00025-x · Cited by 240 · see citing works
Permanne, B., Adessi, C., Saborı́o, G. P., Fraga, S., Frossard, M., Dorpe, J. V., Dewachter, I., Banks, W. A., LEUVEN, F. V., & Soto, C. A. (2002) · The FASEB Journal · doi:10.1096/fj.01-0841fje · Cited by 218 · see citing works
Neidigh, J. W., Fesinmeyer, R. M., Prickett, K. S., & Andersen, N. H. (2001) · Biochemistry · doi:10.1021/bi010902s · Cited by 206 · see citing works
Dvorak, H. F., Nagy, J. A., & Dvořàk, A. M. (1991) · PubMed · Cited by 202 · see citing works
Ghosh, A. K., Ribolla, P. E. M., & Jacobs‐Lorena, M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.241491198 · Cited by 196 · see citing works
Bacich, D. J., Pinto, J. T., Tong, W. P., & Heston, W. D. W. (2001) · Mammalian Genome · doi:10.1007/s003350010240 · Cited by 178 · see citing works
Lecithin vesicular carriers for transdermal delivery of cyclosporin A
Guo, Z., Ping, Q. N., Sun, G., & Jiao, C. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00361-0 · Cited by 158 · see citing works
Improved Lung Delivery from a Passive Dry Powder Inhaler Using an Engineered PulmoSphere® Powder
Duddu, S. P., Sisk, S. A., Walter, Y. H., Tarara, T. E., Trimble, K. R., Clark, A. R., Eldon, M. A., Elton, R. C., Pickford, M., Hirst, P. H., et al. (2002) · Pharmaceutical Research · doi:10.1023/a:1015322616613 · Cited by 150 · see citing works
Trabi, M., Schirra, H. J., & Craik, D. J. (2001) · Biochemistry · doi:10.1021/bi002028t · Cited by 143 · see citing works
Effect of sonication parameters on transdermal delivery of insulin to hairless rats
Boucaud, A., Garrigue, M. A., Machet, L., Vaillant, L., & Patat, F. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00054-8 · Cited by 133 · see citing works
Monkarsh, S. P., Ma, Y., Aglione, A., Bailon, P., Ciolek, D., Debarbieri, B., Graves, M. C., Hollfelder, K., Michel, H., Palleroni, A. V., et al. (1997) · Analytical Biochemistry · doi:10.1006/abio.1997.2128 · Cited by 114 · see citing works
The structure of T6human insulin at 1.0 Å resolution
Smith, G. D., Pangborn, W. A., & BLESSING, R. H. (2003) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444902023685 · Cited by 113 · see citing works
Iontophoresis-Based Transdermal Delivery Systems
Kanikkannan, N. (2002) · BioDrugs · doi:10.2165/00063030-200216050-00003 · Cited by 111 · see citing works
Development of oral insulin: progress and current status
Still, J. (2002) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.207 · Cited by 110 · see citing works
Syed, S., Schuyler, P. D., Kulczycky, M., & Sheffield, W. P. (1997) · Blood · doi:10.1182/blood.v89.9.3243 · Cited by 108 · see citing works
Chemotherapy targeted to tumor vasculature
Arap, W., Pasqualini, R., & Ruoslahti, E. (1998) · Current Opinion in Oncology · doi:10.1097/00001622-199811000-00014 · Cited by 107 · see citing works
The evolving role of oral insulin in the treatment of diabetes using a novel RapidMist? System
Modi, P. J., Mihic, M., & Lewin, A. J. (2002) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.208 · Cited by 106 · see citing works
Vajdos, F. F., Ultsch, M. H., Schaffer, M. L., Deshayes, K., Liu, J., Skelton, N. J., & de Vos, A. M. (2001) · Biochemistry · doi:10.1021/bi0109111 · Cited by 99 · see citing works
Mosca, D. A., Hurst, M. A., So, W., Viajar, B. S. C., Fujii, C. A., & Falla, T. J. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.7.1803-1808.2000 · Cited by 97 · see citing works
Peptides—synthesis, structures and applications
Wallach, J. (1996) · Biochemical Education · doi:10.1016/s0307-4412(97)80792-3 · Cited by 91 · see citing works
Peptide Inhibitors of Beta Amyloid Aggregation
Findeis, M. A. (2002) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026024607508 · Cited by 90 · see citing works
Lowman, H. B., Chen, Y. M., Skelton, N. J., Mortensen, D. L., Tomlinson, E. E., Sadick, M. D., Robinson, I. C. A. F., & CLARK, R. G. (1998) · Biochemistry · doi:10.1021/bi980426e · Cited by 89 · see citing works
Self-citationIn Vivo Lung Deposition of Hollow Porous Particles from a Pressurized Metered Dose Inhaler
Hirst, P. H., Pitcairn, G. R., Weers, J. G., Tarara, T. E., Clark, A. R., Dellamary, L. A., Hall, G., Shorr, J. S., & Newman, S. P. (2002) · Pharmaceutical Research · doi:10.1023/a:1014482615914 · Cited by 89 · see citing works
Multiepitope CD8+ T cell response to a NY-ESO-1 peptide vaccine results in imprecise tumor targeting
Dutoit, V., Taub, R. N., Papadopoulos, K. P., Talbot, S. M., Keohan, M. L., Brehm, M., Gnjatic, S., Harris, P. E., Bisikirska, B. C., Guillaume, P., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci16428 · Cited by 88 · see citing works
Oral Delivery of Biologically Active Parathyroid Hormone
Leone‐Bay, A., Sato, M., Paton, D. R., Hunt, A. H., Sarubbi, D., Carozza, M., Chou, J., McDonough, J., & Baughman, R. (2001) · Pharmaceutical Research · doi:10.1023/a:1010936227570 · Cited by 87 · see citing works
The Factor VII Zymogen Structure Reveals Reregistration of β Strands during Activation
Eigenbrot, C. W., Kirchhofer, D., Dennis, M. S., Santell, L., Lazarus, R. A., Stamos, J. L., & Ultsch, M. H. (2001) · Structure · doi:10.1016/s0969-2126(01)00624-4 · Cited by 85 · see citing works
Lee, K. C., Moon, S. C., Park, M. O., Lee, J. T., Na, D. H., Yoo, S. D., Lee, H. S., & DeLuca, P. P. (1999) · Pharmaceutical Research · doi:10.1023/a:1018861616465 · Cited by 80 · see citing works
Transdermal iontophoretic delivery of bovine insulin and monomeric human insulin analogue
Kanikkannan, N., Singh, J., & Ramarao, P. (1999) · Journal of Controlled Release · doi:10.1016/s0168-3659(98)00184-9 · Cited by 78 · see citing works
Radio-labeled receptor-binding peptides: A new class of radiopharmaceuticals
Boerman, O. C., Oyen, W. J. G., & Corstens, F. H. M. (2000) · Seminars in Nuclear Medicine · doi:10.1053/snuc.2000.7441 · Cited by 76 · see citing works
Horiuchi, M., Baron, G. S., Xiong, L., & Caughey, B. W. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100288200 · Cited by 70 · see citing works
Kim, T. H. (2002) · Biomaterials · doi:10.1016/s0142-9612(01)00365-9 · Cited by 68 · see citing works
Transdermal Delivery of Insulin in Mice by Using Lecithin Vesicles as a Carrier
Guo, Q. P. J. (2000) · Drug Delivery · doi:10.1080/107175400266687 · Cited by 65 · see citing works
Albumin affinity tags increase peptide half-life in vivo
Koehler, M. F. T., Zobel, K., Beresini, M. H., Caris, L. D., Combs, D. L., Paasch, B. D., & Lazarus, R. A. (2002) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(02)00610-8 · Cited by 65 · see citing works
Rapid Identification of Small Binding Motifs with High-Throughput Phage Display
Deshayes, K., Schaffer, M. L., Skelton, N. J., Nakamura, G. R., Kadkhodayan, S., & Sidhu, S. S. (2002) · Chemistry & Biology · doi:10.1016/s1074-5521(02)00129-1 · Cited by 65 · see citing works
Lee, H., & Park, T. G. (2002) · Pharmaceutical Research · doi:10.1023/a:1016113117851 · Cited by 57 · see citing works
Li, F., Dluzewski, A. R., Coley, A. M., Thomas, A. W., Tilley, L. M., Anders, R. F., & Foley, M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m207985200 · Cited by 55 · see citing works
Penetration of Tumor Tissue by Antibodies and Other Immunoproteins
Shockley, T. R., LIN, K., Nagy, J. A., Tompkins, R. G., Dvorak, H. F., & Yarmush, M. L. (1991) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1991.tb27257.x · Cited by 54 · see citing works
Brown, C. K., Modzelewski, R. A., Johnson, C. S., & Wong, M. K. K. (2000) · Annals of Surgical Oncology · doi:10.1007/s10434-000-0743-0 · Cited by 52 · see citing works
Suzuki, Y., Nagase, Y., Iga, K., Kawase, M., Oka, M., Yanai, S., Matsumoto, Y., Nakagawa, S., Fukuda, T., Adachi, H., et al. (2002) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10019 · Cited by 51 · see citing works
Nakamura, G. R., Starovasnik, M. A., Reynolds, M. E., & Lowman, H. B. (2001) · Biochemistry · doi:10.1021/bi0109360 · Cited by 50 · see citing works
Self-citationStable “zeta” peptides that act as potent antagonists of the high-affinity IgE receptor
Nakamura, G. R., Reynolds, M. E., Chen, Y. M., Starovasnik, M. A., & Lowman, H. B. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.022635599 · Cited by 49 · see citing works
Self-citationMachiels, J., van Baren, N., & Marchand, M. (2002) · Seminars in Oncology · doi:10.1053/sonc.2002.35244 · Cited by 48 · see citing works
Skelton, N. J., Chen, Y. M., Dubree, N., Quan, C. L., Jackson, D. Y., Cochran, A. G., Zobel, K., Deshayes, K., Baca, M., Pisabarro, M. T., et al. (2001) · Biochemistry · doi:10.1021/bi0103866 · Cited by 40 · see citing works
Self-citationSynthetic peptides as cancer vaccines
Sundaram, R., Dakappagari, N. K., & Kaumaya, P. T. P. (2002) · Biopolymers · doi:10.1002/bip.10258 · Cited by 34 · see citing works
Bot, A. I., Smith, D. J., Bot, S., Dellamary, L. A., Tarara, T. E., Harders, S., Phillips, W. T., Weers, J. G., & Woods, C. M. (2001) · Pharmaceutical Research · doi:10.1023/a:1010988311640 · Cited by 33 · see citing works
Induction of Specific Immune Responses by Polycation-Based Vaccines
Lührs, P., SCHMIDT, W. A., Kutil, R., Buschle, M., Wagner, S. N., Stingl, G., & Schneeberger, A. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.9.5217 · Cited by 31 · see citing works
Evaluation of alternative strategies for optimizing glycemia: progress to date
Cefalu, W. T. (2002) · The American Journal of Medicine · doi:10.1016/s0002-9343(02)01278-0 · Cited by 28 · see citing works
Physical and Chemical Enhancement of Transdermal Delivery of Triptorelin
Nicoli, S., Rimondi, S., Colombo, P., & Santi, P. (2001) · Pharmaceutical Research · doi:10.1023/a:1013003103169 · Cited by 24 · see citing works
Progress toward a Malaria Vaccine: Efficient Induction of Protective Anti-Malaria Immunity
Tsuji, M., Rodrigues, E. G., & Nussenzweig, R. S. (2001) · Biological Chemistry · doi:10.1515/bc.2001.069 · Cited by 23 · see citing works
Kjeldsen, T., Pettersson, A. F., Drube, L., Kurtzhals, P., Jonassen, I., Havelund, S., Hansen, P. H., & Markussen, J. (1998) · Protein Expression and Purification · doi:10.1006/prep.1998.0876 · Cited by 19 · see citing works
Site Specific 1:1 Opioid:Albumin Conjugate with in Vitro Activity and Long in Vivo Duration
Holmes, D. L., Thibaudeau, K., L'Archevêque, B., Milner, P. G., Ezrin, A. M., & Bridon, D. P. (2000) · Bioconjugate Chemistry · doi:10.1021/bc0000233 · Cited by 19 · see citing works
Phage Display of Peptide Libraries on Protein Scaffolds
Lowman, H. B. (2003) · Humana Press eBooks · doi:10.1385/0-89603-392-9:249 · Cited by 13 · see citing works
Self-citationThe History of Peptide Chemistry
Wieland, T. (1995) · Elsevier eBooks · doi:10.1016/b978-012310920-0/50002-4 · Cited by 7 · see citing works
Flagged first, then by citations
1 of the 84 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Trends in peptide drug discovery
Muttenthaler, M., King, G. F., Adams, D. J., & Alewood, P. F. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-00135-8 · Cited by 2,022 · see citing works
Synthetic therapeutic peptides: science and market
Vlieghe, P., Lisowski, V., Martínez, J., & Khrestchatisky, M. (2009) · Drug Discovery Today · doi:10.1016/j.drudis.2009.10.009 · Cited by 1,487 · see citing works
Antimicrobial peptides: key components of the innate immune system
Pasupuleti, M., Schmidtchen, A., & Malmsten, M. (2011) · Critical Reviews in Biotechnology · doi:10.3109/07388551.2011.594423 · Cited by 804 · see citing works
Evaluation of the use of therapeutic peptides for cancer treatment
Marqus, S., Pirogova, E., & Piva, T. J. (2017) · Journal of Biomedical Science · doi:10.1186/s12929-017-0328-x · Cited by 513 · see citing works
Novel biotechnological applications of bacteriocins: A review
Balciunas, E. M., Castillo Martinez, F. A., Todorov, S. D., Franco, B. D. G. D. M., Converti, A., & Oliveira, R. P. D. S. (2013) · Food Control · doi:10.1016/j.foodcont.2012.11.025 · Cited by 392 · see citing works
“In order to optimally exploit the desired activities of these varied antimicrobial leads, researchers often employ chemical or genetic engineering methods (Lien & Lowman, 2003).”
BackgroundBioactive Molecules Released in Food by Lactic Acid Bacteria: Encrypted Peptides and Biogenic Amines
Pessione, E., & Cirrincione, S. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.00876 · Cited by 333 · see citing works
Peptidomimetics via modifications of amino acids and peptide bonds
Avan, İ., Hall, C. D., & KATRITZKY, A. R. (2014) · Chemical Society Reviews · doi:10.1039/c3cs60384a · Cited by 285 · see citing works
Viral vectors for production of recombinant proteins in plants
Lico, C., Chen, Q., & Santi, L. (2008) · Journal of Cellular Physiology · doi:10.1002/jcp.21423 · Cited by 253 · see citing works
Peptide Phage Display as a Tool for Drug Discovery: Targeting Membrane Receptors
Molek, P., Štrukelj, B., & Bratkovič, T. (2011) · Molecules · doi:10.3390/molecules16010857 · Cited by 188 · see citing works
Goles, M., Sanchez–Daza, A., Cabas-Mora, G., Varón, L. S., Sepúlveda-Yáñez, J., Anvari-Kazemabad, H., Davari, M. D., Uribe-Paredes, R., Olivera‐Nappa, Á., Navarrete, M. A., et al. (2024) · Briefings in Bioinformatics · doi:10.1093/bib/bbae275 · Cited by 180 · see citing works
“Peptides consist of short chains of amino acids, with a molecular weight ranging from 0.5 to 10 kDa [15], and a length ranging from a couple of amino acids up to 100 [16].”
BackgroundInfluentialPhage display as a technology delivering on the promise of peptide drug discovery
Hamzeh‐Mivehroud, M., Alizadeh, A. A., Morris, M. B., Church, W. B., & Dastmalchi, S. (2013) · Drug Discovery Today · doi:10.1016/j.drudis.2013.09.001 · Cited by 163 · see citing works
Recent Advances in Incretin-Based Pharmacotherapies for the Treatment of Obesity and Diabetes
Tan, Q., Akindehin, S. E., Orsso, C. E., Waldner, R. C., DiMarchi, R. D., Müller, T. D., & Haqq, A. M. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.838410 · Cited by 146 · see citing works
“Methods to improve drug efficacy included structural and chemical modifications targeted to increase molecular stability and activity, to improve biodistribution/ bioavailability, and to delay renal elimination (89).”
BackgroundInfluentialHolásková, E., Galuszka, P., Frébort, I., & Öz, M. T. (2015) · Biotechnology Advances · doi:10.1016/j.biotechadv.2015.03.007 · Cited by 140 · see citing works
Synthesis of chitosan–polycaprolactone blend for control delivery of ofloxacin drug
Sahoo, S., Sasmal, A., Nanda, R., Phani, A. R., & Nayak, P. L. (2009) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2009.07.042 · Cited by 133 · see citing works
Peptides for Therapy and Diagnosis of Alzheimer's Disease
Funke, S. A., & Willbold, D. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212799277752 · Cited by 118 · see citing works
Pathania, D., Gupta, D., Kothiyal, N. C., Sharma, G., Eldesoky, G. E., & Naushad, M. (2016) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2015.12.041 · Cited by 102 · see citing works
Fitzgerald, C., Aluko, R. E., Hossain, M., Rai, D. K., & Hayes, M. (2014) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf500983n · Cited by 103 · see citing works
PEG-stabilized lipid disks as carriers for amphiphilic antimicrobial peptides
Morin, M., Reijmar, K., Pränting, M., Engström, Å., Andersson, D. I., & Edwards, K. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.08.029 · Cited by 101 · see citing works
“Several approaches have been attempted to increase peptide half life and stability [2, 3].”
BackgroundTissue Engineering Using Magnetite Nanoparticles
Itô, A., & Kamihira, M. (2011) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-416020-0.00009-7 · Cited by 95 · see citing works
Pimenta, A. M. C., & de Lima, M. E. (2005) · Journal of Peptide Science · doi:10.1002/psc.701 · Cited by 89 · see citing works
Antiviral peptides against the main protease of SARS-CoV-2: A molecular docking and dynamics study
Mahmud, S., Biswas, S., Paul, G. K., Mita, M. A., Afrose, S., Hasan, M. R., Shimu, M. S. S., Uddin, M. A. R., Uddin, M. S., Zaman, S., et al. (2021) · Arabian Journal of Chemistry · doi:10.1016/j.arabjc.2021.103315 · Cited by 88 · see citing works
Peptides Derived from Human Decorin Leucine-rich Repeat 5 Inhibit Angiogenesis
Sulochana, K. N., Fan, H., Jois, S. D. S., Vivekanandan, S., Sun, F., Kini, R. M., & Ge, R. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414320200 · Cited by 86 · see citing works
Funke, S. A., & Willbold, D. (2009) · Molecular BioSystems · doi:10.1039/b904138a · Cited by 86 · see citing works
D‐Peptide and D‐Protein Technology: Recent Advances, Challenges, and Opportunities**
Lander, A. J., Jin, Y., & Luk, L. Y. P. (2022) · ChemBioChem · doi:10.1002/cbic.202200537 · Cited by 85 · see citing works
Kawamoto, M., Horibe, T., Kohno, M., & Kawakami, K. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-359 · Cited by 79 · see citing works
Gracia, S. R., Gaus, K., & Sewald, N. (2009) · Future Medicinal Chemistry · doi:10.4155/fmc.09.97 · Cited by 78 · see citing works
Novel Delivery Systems for Improving the Clinical Use of Peptides
Kovalainen, M., Mönkäre, J., Riikonen, J., Pesonen, U., Vlasova, M. A., Salonen, J., Lehto, V., Järvinen, K., & Herzig, K. (2015) · Pharmacological Reviews · doi:10.1124/pr.113.008367 · Cited by 75 · see citing works
The use of plants for the production of therapeutic human peptides
Lico, C., Santi, L., Twyman, R. M., Pezzotti, M., & Avesani, L. (2012) · Plant Cell Reports · doi:10.1007/s00299-011-1215-7 · Cited by 74 · see citing works
Bacterial display enables efficient and quantitative peptide affinity maturation
Kenrick, S. A., & Daugherty, P. S. (2009) · Protein Engineering Design and Selection · doi:10.1093/protein/gzp065 · Cited by 71 · see citing works
Pathania, D., Gupta, D., Agarwal, S., Asif, M., & Gupta, V. K. (2016) · Materials Science and Engineering C · doi:10.1016/j.msec.2016.03.065 · Cited by 71 · see citing works
Biological properties of low molecular mass peptide dendrimers
Klajnert‐Maculewicz, B., Janiszewska, J., Urbańczyk-Lipkowska, Z., Bryszewska, M. J., Shcharbin, D., & Łabieniec, M. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.10.039 · Cited by 70 · see citing works
Animal-Derived Pharmaceutical Proteins
Redwan, E. M. M. M. (2009) · Journal of Immunoassay and Immunochemistry · doi:10.1080/15321810903084400 · Cited by 69 · see citing works
A novel hybrid peptide targeting EGFR-expressing cancers
Kohno, M., Horibe, T., Haramoto, M., Yano, Y., Ohara, K., Nakajima, O., Matsuzaki, K., & Kawakami, K. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2010.10.021 · Cited by 68 · see citing works
Mlinar, L. B., Chung, E. J., Wonder, E. A., & Tirrell, M. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.06.054 · Cited by 67 · see citing works
“Moreover, peptides have distinct advantages over the use of whole proteins, namely, their shorter structure curtails certain immune responses and increased tissue penetration is observed using peptides due to their smaller size [14,20,21].”
BackgroundHorvat, Š., Mlinarić‐Majerski, K., Glavaš‐Obrovac, L., Jakas, A., Veljković, J., Marczi, S., Kragol, G., Roščić, M., Matković, M., & Milostić-Srb, A. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm051026+ · Cited by 66 · see citing works
Rege, K., Patel, S. J., Megeed, Z., & Yarmush, M. L. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3658 · Cited by 65 · see citing works
Genital Herpes: Insights into Sexually Transmitted Infectious Disease
Jaishankar, D., & Shukla, D. (2016) · Microbial Cell · doi:10.15698/mic2016.09.528 · Cited by 64 · see citing works
Anticancer potential of natural peptides from terrestrial and marine environments: A review
Eghtedari, M., Porzani, S. J., & Nowruzi, B. (2021) · Phytochemistry Letters · doi:10.1016/j.phytol.2021.02.008 · Cited by 63 · see citing works
Castro, T. G., Melle‐Franco, M., Sousa, C. E. A., Cavaco-Paulo, A. M., & Marcos, J. C. (2023) · Biomolecules · doi:10.3390/biom13060981 · Cited by 66 · see citing works
Isidro‐Llobet, A., Guasch, J., Álvarez, M., & Alberício, F. (2005) · European Journal of Organic Chemistry · doi:10.1002/ejoc.200500167 · Cited by 60 · see citing works
Díaz‐Perlas, C., Oller‐Salvia, B., Sánchez‐Navarro, M., Teixidò, M., & Giralt, E. (2018) · Chemical Science · doi:10.1039/c8sc02415d · Cited by 59 · see citing works
Agou, F., Courtois, G., Chiaravalli, J., Baleux, F., Coïc, Y., Traincard, F., Israël, A., & Véron, M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406423200 · Cited by 59 · see citing works
Hsieh, T., Hsu, C., Tsai, C., Chiu, C., Liang, S., Wang, T., Kuo, P., Long, C., & Tsai, E. (2016) · Scientific Reports · doi:10.1038/srep19156 · Cited by 57 · see citing works
Peptibodies: An elegant solution for a long‐standing problem
Cavaco, M. C., Castanho, M. A. R. B., & Neves, V. (2017) · Peptide Science · doi:10.1002/bip.23095 · Cited by 58 · see citing works
Bassiouni, R., Nemec, K. N., Iketani, A., Flores, O., Showalter, A., Khaled, A. S., Vishnubhotla, P., Sprung, R. W., Kaittanis, C., Perez, J. M., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-2502 · Cited by 56 · see citing works
Yap, P., & Gan, C. (2020) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2020.09.005 · Cited by 54 · see citing works
Tau Aggregation Inhibiting Peptides as Potential Therapeutics for Alzheimer Disease
Aillaud, I., & Funke, S. A. (2022) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-022-01230-7 · Cited by 49 · see citing works
“Physiologically, they act as key regulators of biological functions and are attributed with high biological activity, valuable specificity, and in most cases, low toxicity (Lien and Lowman 2003; Danho et al.”
BackgroundAbbreviated nomenclature for cyclic and branched homo‐ and hetero‐detic peptides
Spengler, J., Jiménez, J. C., Burger, K., Giralt, E., & Alberício, F. (2005) · Journal of Peptide Research · doi:10.1111/j.1399-3011.2005.00254.x · Cited by 49 · see citing works
Arranz‐Gibert, P., Guixer, B., Malakoutikhah, M., Muttenthaler, M., Guzmán, F., Teixidò, M., & Giralt, E. (2015) · Journal of the American Chemical Society · doi:10.1021/jacs.5b02050 · Cited by 48 · see citing works
Dammers, C., Yolcu, D., Kukuk, L., Willbold, D., Pickhardt, M., Mandelkow�, E., Horn, A. H. C., Sticht, H., Malhis, M., Will, N., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0167432 · Cited by 48 · see citing works
Quiroz, C., Saavedra, Y. B., Armijo-Galdames, B. O., Amado-Hinojosa, J., Olivera‐Nappa, Á., Sanchez–Daza, A., & Medina-Ortiz, D. (2021) · Database · doi:10.1093/database/baab055 · Cited by 46 · see citing works
Lee, M. W., Bassiouni, R., Sparrow, N. A., Iketani, A., Boohaker, R. J., Moskowitz, C., Vishnubhotla, P., Khaled, A. S., Oyer, J. L., Copik, A. J., et al. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.225 · Cited by 46 · see citing works
Modification of Antimicrobial Peptide with Low Molar Mass Poly(ethylene glycol)
Zhang, G., Han, B., Lin, X., Wu, X., & Yan, H. (2008) · The Journal of Biochemistry · doi:10.1093/jb/mvn134 · Cited by 46 · see citing works
Biomimetic interfaces based on S-layer proteins, lipid membranes and functional biomolecules
Schuster, B., & Sleytr, U. (2014) · Journal of the Royal Society Interface · doi:10.1098/rsif.2014.0232 · Cited by 44 · see citing works
Sequence segregation improves non-covalent protein delivery
Sgolastra, F., Backlund, C. M., Ozay, E. I., deRonde, B. M., Minter, L. M., & Tew, G. N. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.03.387 · Cited by 45 · see citing works
Ribosomally synthesized peptides from natural sources
Singh, N., & Abraham, J. (2014) · The Journal of Antibiotics · doi:10.1038/ja.2013.138 · Cited by 43 · see citing works
Retro‐Enantio N‐Methylated Peptides as β‐Amyloid Aggregation Inhibitors
Grillo‐Bosch, D., Carulla, N., Cruz, M., Sánchez, L., Pujol‐Pina, R., Madurga, S., Rabanal, F., & Giralt, E. (2009) · ChemMedChem · doi:10.1002/cmdc.200900191 · Cited by 42 · see citing works
Ihara, M., Yoshikawa, A., Wu, Y., Takahashi, H., Mawatari, K., Shimura, K., Sato, K., Kitamori, T., & Ueda, H. (2009) · Lab on a Chip · doi:10.1039/b915516c · Cited by 40 · see citing works
Shukeir, N., Arakelian, A., Chen, G., Garde, S. V., Ruiz, M. T., Panchal, C. J., & Rabbani, S. A. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0788 · Cited by 40 · see citing works
“Use of these peptides is particularly attractive because they can be easily synthesized at low cost, they exhibit higher tissue permeability, and they can be conjugated to chemotherapeutic agents for their targeted delivery to avert cytotoxic agents associated side effects (34, 35, 37, 39, 40).”
BackgroundAnalysis of peptides and proteins using sub-2μm fully porous and sub 3-μm shell particles
Staub, A., Zurlino, D., Rudaz, S. L., Veuthey, J., & Guillarme, D. (2011) · Journal of Chromatography A · doi:10.1016/j.chroma.2011.07.051 · Cited by 39 · see citing works
Molecular design and synthesis of self-assembling camptothecin drug amphiphiles
Cheetham, A. G., Lin, Y., Lin, R., & Cui, H. (2017) · Acta Pharmacologica Sinica · doi:10.1038/aps.2016.151 · Cited by 39 · see citing works
Expression of SMAP-29 cathelicidin-like peptide in bacterial cells by intein-mediated system
Morassutti, C., Amicis, F. D., Bandiera, A., & Marchetti, S. (2004) · Protein Expression and Purification · doi:10.1016/j.pep.2004.11.006 · Cited by 38 · see citing works
Dahan, I. M., & Pick, E. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1007-4 · Cited by 36 · see citing works
Hamzeh‐Mivehroud, M., Mahmoudpour, A., & Dastmalchi, S. (2011) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2011.01282.x · Cited by 35 · see citing works
Ding, S., Li, Z., Cheng, Y., Du, C., Gao, J., Zhang, Y., Zhang, N., Li, Z., Chang, N., & Hu, X. (2018) · Nanotechnology · doi:10.1088/1361-6528/aace10 · Cited by 35 · see citing works
Kawamoto, M., Horibe, T., Kohno, M., & Kawakami, K. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-0357 · Cited by 35 · see citing works
Kato, G., Shimizu, Y., Arai, Y., Suzuki, N., Sugamori, Y., Maeda, M., Takahashi, M., Tamura, Y., Wakabayashi, N., Murali, R., et al. (2015) · Arthritis Research & Therapy · doi:10.1186/s13075-015-0753-8 · Cited by 35 · see citing works
The yeast two-hybrid system and its role in drug discovery
Lentze, N., & Auerbach, D. (2008) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.12.4.505 · Cited by 34 · see citing works
Tada, N., Horibe, T., Haramoto, M., Ohara, K., Kohno, M., & Kawakami, K. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.03.030 · Cited by 34 · see citing works
Ding, S., Hu, X., Guan, P., Zhang, N., Ji, L., Gao, X., Zhang, X. Y., Ding, X., & Du, C. (2017) · Journal of Materials Science · doi:10.1007/s10853-017-1005-x · Cited by 33 · see citing works
Peptides to Tackle Leishmaniasis: Current Status and Future Directions
Robles-Loaiza, A. A., Pinos-Tamayo, E. A., Mendes, B. D. S., Teixeira, C. A. S., Alves, C., Gomes, P. A. C., & Almeida, J. R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094400 · Cited by 32 · see citing works
“ferent cell types, such as bacterial, fungal, parasitic and tumoral [68,82,83].”
BackgroundAmphipathic tail-anchoring peptide is a promising therapeutic agent for prostate cancer treatment
De, G., Ko, J., Tan, T., Hua Zhu, C., Li, H., & Ma, J. (2014) · Oncotarget · doi:10.18632/oncotarget.2301 · Cited by 32 · see citing works
Armishaw, C. J., Jensen, A. A., Balle, L. D., Scott, K. C. M., Sørensen, L., & Strømgaard, K. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3458 · Cited by 32 · see citing works
Non-natural Amino Acids Containing Peptide-Capped Gold Nanoparticles for Drug Delivery Application
Parween, S., Ali, A., & Chauhan, V. S. (2013) · ACS Applied Materials & Interfaces · doi:10.1021/am4017973 · Cited by 31 · see citing works
Montero, A., Mann, E., & Herradón, B. (2004) · European Journal of Organic Chemistry · doi:10.1002/ejoc.200400166 · Cited by 31 · see citing works
Design of a Hyperstable Protein by Rational Consideration of Unfolded State Interactions
Anil, B., Craig‐Schapiro, R., & Raleigh, D. P. (2006) · Journal of the American Chemical Society · doi:10.1021/ja057874b · Cited by 31 · see citing works
Montero, A., Mann, E., & Herradón, B. (2004) · Tetrahedron Letters · doi:10.1016/j.tetlet.2004.11.109 · Cited by 30 · see citing works
Peptipedia v2.0: a peptide sequence database and user-friendly web platform. A major update
Cabas-Mora, G., Daza, A., Soto-García, N., Garrido, V., Alvarez, D., Navarrete, M., Sarmiento-Varón, L., Sepúlveda Yañez, J. H., Davari, M. D., Cadet, F., et al. (2024) · Database · doi:10.1093/database/baae113 · Cited by 35 · see citing works
Differently Selected d -Enantiomeric Peptides Act on Different Aβ Species
Bartnik, D., Funke, S. A., Andrei‐Selmer, L., Bacher, M., Dodel, R. C., & Willbold, D. (2009) · Rejuvenation Research · doi:10.1089/rej.2009.0924 · Cited by 27 · see citing works
Jaishankar, D., Yakoub, A. M., Bogdanov, A., Vályi-Nagy, T., & Shukla, D. (2014) · Journal of Virology · doi:10.1128/jvi.02979-14 · Cited by 26 · see citing works
Bioactive Synthetic Peptides for Oral Tissues Regeneration
Bermúdez, M., Hoz, L., Montoya, G. A., Campos, M. N., Pérez‐Soria, A., Romo, E., Soto‐Barreras, U., Garnica-Palazuelos, J. C., Aguilar‐Medina, M., Ramos‐Payán, R., et al. (2021) · Frontiers in Materials · doi:10.3389/fmats.2021.655495 · Cited by 26 · see citing works
Bousquet, G., Feugeas, J., Gu, Y., Lebœuf, C., Bouchtaoui, M. E., Lu, H., Espié, M., Janin, A., & Benedetto, M. D. (2019) · Oncotarget · doi:10.18632/oncotarget.27312 · Cited by 25 · see citing works
Baazaoui, N., & Iqbal, K. (2022) · Biomolecules · doi:10.3390/biom12101409 · Cited by 24 · see citing works
Peptides in Dentistry: A Scoping Review
Hardan, L., Chedid, J. C. A., Bourgi, R., Cuevas‐Suárez, C. E., Łukomska−Szymańska, M., Tosco, V., Avila, A. J. M., Jabra, M., Salloum-Yared, F., Kharouf, N., et al. (2023) · Bioengineering · doi:10.3390/bioengineering10020214 · Cited by 24 · see citing works
Li, H., Rose, M. J., Holder, J. R., Wright, M., Miranda, L. P., & James, C. A. (2011) · Journal of the American Society for Mass Spectrometry · doi:10.1007/s13361-011-0180-2 · Cited by 24 · see citing works
“Peptides are potentially attractive therapeutic agents due to their high biological activity associated with high target specificity and low toxicity [1, 2].”
BackgroundErdağ, B., Balcıoğlu, B. K., Kumbasar, A., Çelikbıçak, Ö., Zeder‐Lutz, G., Altschuh, D., Salih, B., & Baysal, K. (2007) · Molecular Biotechnology · doi:10.1385/mb:35:1:51 · Cited by 24 · see citing works
Sharma, P., Singh, N., Garg, R., Haq, W., & Dube, A. (2004) · Peptides · doi:10.1016/j.peptides.2004.06.011 · Cited by 24 · see citing works
Microneedle-Assisted Skin Permeation by Nontoxic Bioengineerable Gas Vesicle Nanoparticles
Andar, A. U., Karan, R., Pecher, W. T., Dassarma, P. A., Hedrich, W. D., Stinchcomb, A. L., & DasSarma, S. (2017) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b00859 · Cited by 24 · see citing works
Peptides as Diagnostic, Therapeutic, and Theranostic Tools: Progress and Future Challenges
Thakur, R., Suri, C. R., Kaur, I. P., & Rishi, P. (2022) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.2022040322 · Cited by 23 · see citing works
Dhakne, P., Pillai, M. S., Mishra, S., Chatterjee, B., Tekade, R. K., & Sengupta, P. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.188906 · Cited by 23 · see citing works
Accommodating fluorinated amino acids in a helical peptide environment
Nyakatura, E. K., Reimann, O., Vagt, T., Salwiczek, M., & Koksch, B. (2013) · RSC Advances · doi:10.1039/c3ra41110a · Cited by 23 · see citing works
Liquid-Spray or Dry-Powder Systems for Inhaled Delivery of Peptide and Proteins?
Garcia‐Contreras, L., & Smyth, H. D. C. (2005) · American Journal of Drug Delivery · doi:10.2165/00137696-200503010-00004 · Cited by 23 · see citing works
Elfgen, A., Santiago‐Schübel, B., Gremer, L., Kutzsche, J., & Willbold, D. (2017) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2017.07.015 · Cited by 22 · see citing works
The potential of plant and fungal proteins in the control of gastrointestinal nematodes from animals
Soares, A. M. D. S., Wanderley, L. F., & Costa, L. M. (2019) · Revista Brasileira de Parasitologia Veterinária/Brazilian Journal of Veterinary Parasitology · doi:10.1590/s1984-29612019046 · Cited by 21 · see citing works
Camargo, L. C., Campos, G. A. A., Galante, P., Biolchi, A. M., Gonçalves, J. C., Lopes, K. S., & Mortari, M. R. (2017) · Neuropeptides · doi:10.1016/j.npep.2017.11.010 · Cited by 21 · see citing works
Protein Language Models and Machine Learning Facilitate the Identification of Antimicrobial Peptides
Medina-Ortiz, D., Contreras, S., Fernández, D., Soto-García, N., Moya-Barría, I., Cabas-Mora, G., & Olivera‐Nappa, Á. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25168851 · Cited by 20 · see citing works
“Peptides are versatile, bioactive, short amino acid chains, with lengths of 5–15 amino acids and rarely exceeding 30 amino acids [1,2].”
BackgroundReijmar, K., Edwards, K., Andersson, K., & Hernández, V. A. (2016) · Langmuir · doi:10.1021/acs.langmuir.6b03012 · Cited by 20 · see citing works
Anti-inflammatory defense mechanisms of Entamoeba histolytica
Silva‐García, R., & Rico-Rosillo, G. (2010) · Inflammation Research · doi:10.1007/s00011-010-0261-x · Cited by 20 · see citing works
Zheng, Y., Gu, Q., & Xu, X. (2012) · Acta Ophthalmologica · doi:10.1111/j.1755-3768.2012.02476.x · Cited by 19 · see citing works
Drug and Anti-Viral Peptide Design to Inhibit the Monkeypox Virus by Restricting A36R Protein
Miah, M. M., Tabassum, N., Zinnia, M. A., & Islam, A. B. M. M. K. (2022) · Bioinformatics and Biology Insights · doi:10.1177/11779322221141164 · Cited by 19 · see citing works
- Authors
- Lien, S., & Lowman, H. B.
- Affiliations
- Genentech (US)
- Corresponding author
- Lowman, Henry B
- Venue
- Trends in Biotechnology
- Publisher
- Elsevier BV
- Published
- 2003-12
- Volume
- 21
- Issue
- 12
- Pages
- 556-562
- ISSN
- 0167-7799 (ISSN-L)
- OpenAlex
- W4243226078
- Cited by
- 209
- References
- 84
- Citations by year
- 2026: 9 · 2025: 8 · 2024: 10 · 2023: 10 · 2022: 13 · 2021: 12 · 2020: 6 · 2019: 5 · 2018: 6 · 2017: 13 · 2016: 11 · 2015: 7 · 2014: 16 · 2013: 14 · 2012: 9
- FWCI
- 0.52
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Trends in biotechnology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chemical Synthesis and Analysis
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Keywords
- peptide therapeutics, peptide libraries, high-throughput screening, Alzheimer's disease, cancer therapy
- MeSH terms
- Biotechnology, Humans, Peptides, Technology, Pharmaceutical, Drug Design, Drug Delivery Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review